{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:24:18Z","timestamp":1787793858504,"version":"build-2784847793"},"reference-count":9,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,1,8]]},"abstract":"<jats:p>A 43-year-old woman with a history of recently diagnosed metastatic melanoma was commenced on systemic therapy with nivolumab, an anti-programmed cell death-1 monoclonal antibody and one of an increasing group of the so-called \u2018immune checkpoint inhibitors\u2019. She experienced a dramatic complete response within 6\u2009months of initiation. However, in addition to developing incident autoimmune hypothyroidism, she also developed progressive fatigue, proximal weakness, myalgia and dysphagia. Initial investigations with blood tests, electrophysiology and a muscle biopsy were non-specific or normal. Subsequent examination revealed \u2018woody\u2019 thickening of the subcutaneous tissues of the forearms, thighs and calves consistent with fasciitis. MRI and a full-thickness skin\u2013muscle biopsy were ultimately diagnostic of a likely iatrogenic autoimmune myofasciitis. The clinical manifestations only responded partly to prednisolone 30\u2009mg orally and treatment was escalated to include intravenous immunoglobulin. At 3\u2009months, this has only resulted in a modest incremental improvement.<\/jats:p>","DOI":"10.1136\/bcr-2017-223249","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T08:50:14Z","timestamp":1518079814000},"page":"bcr-2017-223249","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab"],"prefix":"10.1136","volume":"2018","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6550-1995","authenticated-orcid":false,"given":"Matthew JS","family":"Parker","sequence":"first","affiliation":[{"name":"Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK"},{"name":"Manchester Academic Health Science Centre, Musculoskeletal Biomedical Research Centre, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Roberts","sequence":"additional","affiliation":[{"name":"Greater Manchester Neurosciences Centre, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C","family":"Lorigan","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK"},{"name":"The Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G","family":"du Plessis","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[{"name":"Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK"},{"name":"Manchester Academic Health Science Centre, Musculoskeletal Biomedical Research Centre, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60958-2"},{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.58"},{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.3","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/acr.23177","article-title":"Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: a systematic review of the literature","volume":"69","author":"Cappelli","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.005"},{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160763"},{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.6","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.mayocp.2017.03.016","article-title":"Scleroderma induced by pembrolizumab: a case series","volume":"92","author":"Barbosa","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.7","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0186"},{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.8","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/rheumatology\/kex369","article-title":"Immune checkpoint inhibitor-induced myo-fasciitis","volume":"56","author":"Daoussis","year":"2017","journal-title":"Rheumatology"},{"key":"2025082700514719000_2018.feb08_1.bcr-2017-223249.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.RHU.0000049694.12335.80","article-title":"Fasciitis: what is the significance of various forms?","volume":"9","author":"Shiozawa","year":"2003","journal-title":"J Clin Rheumatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-223249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:51:52Z","timestamp":1756281112000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-223249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":9,"alternative-id":["10.1136\/bcr-2017-223249"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-223249","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]}}}